Nutritional status of patients with amyotrophic lateral sclerosis: Relation to the proximity of death

被引:209
作者
Kasarskis, EJ
Berryman, S
Vanderleest, JG
Schneider, AR
McClain, CJ
机构
[1] UNIV KENTUCKY, DEPT NEUROL, LEXINGTON, KY 40536 USA
[2] UNIV KENTUCKY, DEPT INTERNAL MED, LEXINGTON, KY 40536 USA
[3] UNIV KENTUCKY, GRAD PROGRAM NUTR SCI, LEXINGTON, KY 40536 USA
[4] UNIV KENTUCKY, GRAD PROGRAM TOXICOL, LEXINGTON, KY 40536 USA
[5] UNIV KENTUCKY, GEN CLIN RES CTR, LEXINGTON, KY 40536 USA
关键词
amyotrophic lateral sclerosis; ALS; nutrition; energy intake; protein intake; micronutrients; calcium; zinc;
D O I
10.1093/ajcn/63.1.130
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle atrophy and weakness. Although dysphagia is a universal feature of this illness, the nutritional and metabolic status of ALS patients has received little attention. We performed serial measurements of muscle power, body composition, energy expenditure, nitrogen balance, and dietary intake on ALS patients on three occasions over 6 mo in the General Clinical Research Center of the University of Kentucky Medical Center. Data were analyzed in reference to the time of death. Regression analysis demonstrated progressive decreases in body fat, lean body mass, muscle power, and nitrogen balance and an increase in resting energy expenditure as death approached. The changes in body composition were greater in males. Energy and protein consumption averaged 84% and 126% of the recommended dietary allowances, respectively, but did not correlate with complaints of dysphagia. We conclude that ALS patients have a chronically deficient intake of energy and recommend augmentation of energy intake rather than the consumption of high-protein nutritional supplements.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 40 条
[31]  
SMITH RA, 1991, HDB CLIN NEUROLOGY, P459
[32]   ASSOCIATION OF AMYOTROPHIC LATERAL SCLEROSIS ( MOTOR NEURON DISEASE ) + CARBOHYDRATE INTOLERANCE CLINICAL STUDY [J].
STEINKE, J ;
TYLER, HR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1964, 13 (11) :1376-&
[33]   ISOKINETIC ASSESSMENT IN ALS [J].
SUFIT, R ;
CLOUGH, JA ;
SCHRAM, M ;
CONRAD, J ;
ERICKSON, L ;
BROOKS, BR .
NEUROLOGIC CLINICS, 1987, 5 (02) :197-212
[34]   AMYOTROPHIC LATERAL SCLEROSIS .2. ETIOPATHOGENESIS [J].
TANDAN, R ;
BRADLEY, WG .
ANNALS OF NEUROLOGY, 1985, 18 (04) :419-431
[35]   AMYOTROPHIC LATERAL SCLEROSIS .1. CLINICAL-FEATURES, PATHOLOGY, AND ETHICAL ISSUES IN MANAGEMENT [J].
TANDAN, R ;
BRADLEY, WG .
ANNALS OF NEUROLOGY, 1985, 18 (03) :271-280
[36]   PANCREATIC FUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS [J].
UTTERBACK, RA ;
CUMMINS, AJ ;
CAPE, CA ;
GOLDENBERG, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1970, 33 (04) :544-+
[37]  
Welnetz K, 1983, Can Nurse, V79, P30
[38]   CALCIUM AND VITAMIN-D METABOLISM IN GUAMANIAN CHAMORROS WITH AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSONISM-DEMENTIA [J].
YANAGIHARA, R ;
GARRUTO, RM ;
GAJDUSEK, DC ;
TOMITA, A ;
UCHIKAWA, T ;
KONAGAYA, Y ;
CHEN, KM ;
SOBUE, I ;
PLATO, CC ;
GIBBS, CJ .
ANNALS OF NEUROLOGY, 1984, 15 (01) :42-48
[39]  
YASE Y, 1980, NEUROTOXICOLOGY, V1, P101
[40]   PATHOGENESIS OF AMYOTROPHIC LATERAL SCLEROSIS [J].
YASE, Y .
LANCET, 1972, 2 (7772) :292-&